Cargando…
Ganfule capsule alleviates bile duct ligation-induced liver fibrosis in mice by inhibiting glutamine metabolism
Background: Liver fibrosis is a pathological outcome of a variety of liver diseases, and it can also progress into liver cirrhosis and liver cancer. Specific liver antifibrotic drugs have not been clinically approved yet. Studies have demonstrated the protective effects of Ganfule capsule (GFL) on t...
Autores principales: | Ke, Chang, Gao, Jianlong, Tu, Jiyuan, Wang, Yan, Xiao, Yangxin, Wu, Yuan, Liu, Yanju, Zhou, Zhongshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585157/ https://www.ncbi.nlm.nih.gov/pubmed/36278176 http://dx.doi.org/10.3389/fphar.2022.930785 |
Ejemplares similares
-
Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism
por: Wang, Yan, et al.
Publicado: (2023) -
Therapeutic effects and mechanism of Atractylodis rhizoma in acute lung injury: Investigation based on an Integrated approach
por: Shi, Kun, et al.
Publicado: (2023) -
Melatonin Alleviates Liver Apoptosis in Bile Duct Ligation Young Rats
por: Sheen, Jiunn-Ming, et al.
Publicado: (2016) -
Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Wei, Shizhang, et al.
Publicado: (2020) -
Lactobacillus Aggravate Bile Duct Ligation-Induced Liver Inflammation and Fibrosis in Mice
por: Roh, Yoon Seok, et al.
Publicado: (2018)